Meglucon 500 mg tablete s produljenim oslobađanjem
| Name | Meglucon 500 mg tablete s produljenim oslobađanjem |
|---|---|
| Marketing Authorisation Number | HR-H-665797041 |
| Active Substance | metforminklorid |
| Composition | jedna tableta s produljenim oslobađanjem sadrži 500 mg metforminklorida što odgovara 390 mg metformina |
| Pharmaceutical Form | Tableta s produljenim oslobađanjem |
| Manufacturer | Salutas Pharma GmbH, Barleben, Njemačka Lek Pharmaceuticals d.d., Ljubljana, Slovenija |
| Marketing Authorisation Holder | Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska |
| Marketing Authorisation Date | 15.03.2023 |
| MA Period of Validity | 15.03.2028 |
| Classification Number | UP/I-530-09/21-01/23 |
| Registration Number | 381-12-01/70-23-10 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | A10BA02 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
